ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OTLY vs MED // ALTMAN Z-SCORE & DEBT/EQUITY

Oatly Group AB (NASDAQ) VS. MEDIFAST INC (NYSE) • 15-METRIC TALLY: OTLY 1 — MED 2
■ METRIC PARITY
balance-sheet
4.71
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OTLY VS. MED) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OTLY MED SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 71.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -10.20% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — 0.91% — TIE /fcf-yield <GO>
Operating Margin — -3.70% — TIE /operating-margins <GO>
Net Profit Margin — -4.90% — TIE /net-margins <GO>
Revenue Growth (YoY) — -36.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.14% -0.14 MED /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 4.71 — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 5/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 22.4 54.3 -31.83 MED /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $255.3M $137.1M $118.2M OTLY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OTLY REV MED REV OTLY GROSS % MED GROSS % OTLY FCF MED FCF
FY 2025 — $385.8M — 71.3% — $1.2M
FY 2024 — $602.5M — 73.8% — $17.0M
FY 2023 — $1.07B — — — $147.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OTLY // BETA —
MED // BETA —